UNSPSC 51333600: Antipsychotic pyrimidines

Antipsychotic drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.

UNSPSC 51333600 Antipsychotic pyrimidines is a Class code that in recent state and local procurement activity does not align with its nominal pharmaceutical scope. The three opportunities posted in the source—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's RFI on direct-to-manufacturer prescription programs, and Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and OTC products—fall outside the antipsychotic pyrimidines category. The naloxone solicitation addresses overdose reversal agents; the Texas RFI explores pharmacy benefit program design rather than specific drug classes; and the MMCAP procurement spans generic pharmaceuticals across all therapeutic categories, not antipsychotics. The code shows little relevant recent activity, and the mismatch between the code's intended scope and the opportunities tagged against it suggests potential miscoding in the state and local procurement system.

The recent opportunities do indicate broader state and local pharmaceutical procurement activity across multiple issuing bodies—a county health department, a state HHS agency, and a multistate cooperative purchasing alliance serving state and local facilities across Minnesota and Oregon. Seminole County's IFB for naloxone (due July 26, 2023) required electronic bidding with quarterly deliveries and FEMA compliance. Texas HHS's RFI (response deadline April 3, 2026) explored vendor capacity for direct manufacturer contracting outside traditional pharmacy benefit manager channels. MMCAP's RFP (due March 26, 2026) sought generic pharmaceutical manufacturers willing to supply through three authorized wholesalers, with price competitiveness weighted at seventy-five percent and contract term through June 30, 2028. These solicitations reflect state and local demand for pharmaceuticals across multiple channels and contracting models, though they do not represent activity under the antipsychotic pyrimidines code specifically.